Concepedia

Publication | Open Access

Low-dose continuous oral fosfestrol is highly active in 'hormone-refractory' prostate cancer

DOIFull Paper Access

42

Citations

18

References

2000

Year

Mauro Orlando, Matías Chacón, Ghada M. Salum, Dolores Romero Chacon
Annals of Oncology

References

YearCitations

Page 1